Ambica: One in Health

Ambica is currently the sole distributor of Reteplase in the Philippines and in partnership with its affiliate company - Ambitech Biopharmaceuticals Inc., they have successfully developed an anti-venom serum against snakebites. Product Description:
• Reteplase 18mg Lyophilized Powder for Solution for Intravenous Injection (MIRel) - the first 3rd Generation recombinant tissue plasminogen activator (rTPA) in the Philippines. The rationale behind the development of MIRel-Reteplase was to find a faster thrombolytic agent compared to approved dosage regimens of standard thrombolytics without increasing the risk of thrombolysis. The second aim was to find a substance with a longer effective half-life as compared to approved dosage regimens of standard thrombolytics in order to facilitate the method of administration.

• Anti-Snake Venom Serum (Taradoc) - a polyvalent enzyme refined anti-venom that can treat bites from any of the 3) snake specifies of: (a.) Southern Philippine Cobra (Naja Samarensis); and (c.) Philippine King Cobra (Ophiophagus Hannah). Some other snake species with the same toxicity level can also be treated using this polyvalent enzyme refined anti-venom as it exhibits cross-sensitivity with the other snake varieties such as the sea snake, the Philippines pit viper and the coral snakes.